Citric Acid

Citric Acid

SCHEMBL3289690

CCN(O)CC.CCN(O)CC.CCN(O)CC.O=C(O)CC(O)(CC(=O)O)C(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 3/20 0.47
ESR1 known ✓ P03372 1/20 0.35
ESR2 known ✓ Q92731 1/20 0.35
ALDH1A1 P00352 3/20 0.65
KDM4E B2RXH2 6/20 0.50
LMNA P02545 5/20 0.50
MAPT P10636 3/20 0.50
TSHR P16473 3/20 0.50
ALOX15 P16050 1/20 0.50
CYP2D6 P10635 5/20 0.47
CYP1A2 P05177 4/20 0.47
KMT2A Q03164 3/20 0.47
HMGCR P04035 1/20 0.41
CHRM1 P11229 1/20 0.41
TBXA2R P21731 1/20 0.41
ADRA1A P35348 1/20 0.41
HIF1A Q16665 3/20 0.39
CYP2C19 P33261 2/20 0.39
SLC13A5 Q86YT5 3/20 0.38
TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL6313398 1.00 ALDH1A1 (0.65) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL10492812 0.90 ALDH1A1 (0.58) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL239487 0.84 ALDH1A1 (0.68) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL2064710 0.84 ALDH1A1 (0.68) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL2064712 0.84 ALDH1A1 (0.68) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL31272367 0.84 ALDH1A1 (0.83) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL28138648 0.83 ALDH1A1 (0.65) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL226489 0.81 ALDH1A1 (0.79) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL437150 0.81 ALDH1A1 (0.79) ALDH1A1KDM4ELMNAMAPTTSHR
Citric Acid SCHEMBL6429247 0.81 ALDH1A1 (0.79) ALDH1A1KDM4ELMNAMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7018454-B2 Ink jet ink and recording material CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-03-28 US claimed
EP-1572817-A1 INK-JET INK AND RECORDING MATERIAL Ciba SC Holding AG (CH) 2005-09-14 EP claimed
WO-2004056931-A1 INK-JET INK AND RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-07-08 WO claimed
US-20040126510-A1 Ink jet ink and recording material CIBA SPECIALTY CHEMICALS CORP. 2004-07-01 US claimed
US-6599326-B1 Composition having reduced loss of brightness and enhanced resistance to yellowing which comprises chemical paper which may still contain traces of lignin and N,N-dialkylhydroxylamine or derivative or salt thereof CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-29 US claimed
EP-1718271-B1 STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS BASF SE (DE) 2014-10-08 EP disclosed
US-7718096-B2 Stabilized electrochromic media CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-05-18 US disclosed
US-7618618-B2 Stabilized body care products, household products, textiles and fabrics CIBA SPECIALTY CHEMICALS CORP. (US) 2009-11-17 US disclosed
US-7618644-B2 Sterically hindered amine salts having an N-(alkoxy, cycloalkoxy or aralkoxy)2,2,6,6-tetraalkylsubstituted piperidine moiety; discoloration inhibition, colorfastness CIBA SPECIALTY CHEMICALS CORP. (US) 2009-11-17 US disclosed
US-20090074681-A1 Sterically hindered amine salts having an N-(alkoxy, cycloalkoxy or aralkoxy)2,2,6,6-tetraalkylsubstituted piperidine moiety; discoloration inhibition, colorfastness LUPIA JOSEPH A 2009-03-19 US disclosed
US-7429545-B2 Stabilized body care products, household products, textiles and fabrics CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-09-30 US disclosed
EP-1896550-A1 STABILIZED ELECTROCHROMIC MEDIA Ciba Specialty Chemicals Holding Inc. (CH) 2008-03-12 EP disclosed
US-6599326-B1 Composition having reduced loss of brightness and enhanced resistance to yellowing which comprises chemical paper which may still contain traces of lignin and N,N-dialkylhydroxylamine or derivative or salt thereof CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-29 US disclosed
US-20020174964-A1 Inhibition of pulp and paper yellowing using hydroxylamines and other coadditives SELTZER RAYMOND (US) 2002-11-28 US disclosed
US-20020088574-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES CIBA SPECIALTY CHEMICALS CORP. 2002-07-11 US disclosed
CN-1355835-A Antigelling agent for hydrocarbon mixture containing conjugated and method for preventing clogging of apparatus for separating and purifying mixture NIPPON ZEON CO (JP) 2002-06-26 CN disclosed
EP-1184444-A1 ANTIGELLING AGENT FOR HYDROCARBON MIXTURE CONTAINING CONJUGATED DIENE AND METHOD OF PREVENTING CLOGGING OF APPARATUS FOR SEPARATING AND PURIFYING THE MIXTURE Nippon Zeon Co., Ltd. (JP) 2002-03-06 EP disclosed
EP-1131483-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES Ciba SC Holding AG (CH) 2001-09-12 EP disclosed
EP-1061059-A1 POLYMERIZATION-INHIBITING COMPOSITION, POLYMERIZATION INHIBITOR AND METHOD FOR INHIBITING POLYMERIZATION NIPPON ZEON CO., LTD. (JP) 2000-12-20 EP disclosed
WO-2000024963-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074681-A1 Sterically hindered amine salts having an N-(alkoxy, cycloalkoxy or aralkoxy)2,2,6,6-tetraalkylsubstituted piperidine moiety; discoloration inhibition, colorfastness DEK, CUTA, ANKK1 MEN1 4734/4885ESR1 4799/4885ESR2 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.